XYLOCAINE 2% lidocaine (lignocaine) hydrochloride anhydrous 200mg/10mL injection ampoule Export Australia - English - Department of Health (Therapeutic Goods Administration)

xylocaine 2% lidocaine (lignocaine) hydrochloride anhydrous 200mg/10ml injection ampoule export

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 20 mg/ml - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; water for injections - indicated for the production of local or regional anesthesia by infiltration techniques including percutaneous injection, peripheral nerve block techniques such as brachial plexus & intercostal blocks and central neural techniques including epidural & caudal blocks.

LIDOCAINE HYDROCHLORIDE MONOHYDRATE powder United States - English - NLM (National Library of Medicine)

lidocaine hydrochloride monohydrate powder

sa3, llc - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987) - lidocaine hydrochloride monohydrate powder intradermal injection system is indicated for use on intact skin to provide topical local analgesia prior to venipuncture or peripheral intravenous cannulation, in children 3–18 years of age. lidocaine hydrochloride monohydrate powder intradermal injection system is indicated for use on intact skin to provide topical local analgesia prior to venipuncture in adults. lidocaine hydrochloride monohydrate is contraindicated in patients with a known history of sensitivity to local anesthetics of the amide type. lidocaine hydrochloride monohydrate powder intradermal injection system was not formally evaluated for effects on reproduction. significant systemic exposure to lidocaine is not expected under recommended conditions of use of lidocaine hydrochloride monohydrate powder intradermal injection system as lidocaine levels were below the limit of detection in human studies. lidocaine has been previously tested for reproductive toxicity in animal studies, however. the follo

2% XYLOCAINE DENTAL WITH ADRENALINE 1:80,000 2.2mL injection cartridge Australia - English - Department of Health (Therapeutic Goods Administration)

2% xylocaine dental with adrenaline 1:80,000 2.2ml injection cartridge

dentsply sirona pty ltd - adrenaline (epinephrine) acid tartrate, quantity: 22.7 microgram/ml (equivalent: adrenaline (epinephrine), qty 12.5 microgram/ml); lidocaine hydrochloride monohydrate, quantity: 21.3 mg/ml (equivalent: lidocaine hydrochloride, qty 20 mg/ml) - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections; sodium metabisulfite; sodium hydroxide - indications as at 25 july 2003 : lidocaine (lignocaine) solutions are indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques. lidocaine (lignocaine) solutions with adrenaline (epinephrine) are recommended for oral surgery requiring prolonged duration of anaesthesia and haemostasis.

XYLOCAINE VISCOUS lidocaine (lignocaine) hydrochloride 21.3 mg/mL oral liquid bottle Australia - English - Department of Health (Therapeutic Goods Administration)

xylocaine viscous lidocaine (lignocaine) hydrochloride 21.3 mg/ml oral liquid bottle

aspen pharmacare australia pty ltd - lidocaine hydrochloride monohydrate, quantity: 21.3 mg/ml (equivalent: lidocaine hydrochloride, qty 20 mg/ml) - oral liquid - excipient ingredients: sodium hydroxide; propyl hydroxybenzoate; methyl hydroxybenzoate; saccharin sodium; purified water; carmellose sodium; flavour - indicated for the relief of pain & discomfort associated with:,-irritated or inflamed mucous membranes of the mouth, pharynx and upper gastrointestinal tract, e.g. post-tonsillectomy sore throat, dumping syndrome;,-introduction of instruments and catheters into the respiratory and gastrointestinal tract

Lidocaine-Baxter New Zealand - English - Medsafe (Medicines Safety Authority)

lidocaine-baxter

baxter healthcare ltd - lidocaine hydrochloride monohydrate 10.66 mg/ml equivalent to lidocaine hydrochloride 10.0 mg/ml - solution for injection - 1% w/v - active: lidocaine hydrochloride monohydrate 10.66 mg/ml equivalent to lidocaine hydrochloride 10.0 mg/ml excipient: hydrochloric acid nitrogen sodium chloride sodium hydroxide water for injection - lidocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: local infiltration; minor or major nerve blocks; epidural block; arthroscopy; intravenous regional anaesthesia.

LIDOCAINE B.BRAUN 1 % Israel - English - Ministry of Health

lidocaine b.braun 1 %

lapidot medical import and marketing ltd - lidocaine hydrochloride monohydrate - solution for injection - lidocaine hydrochloride monohydrate 10 mg/ml - lidocaine - local and regional anaesthesia.

Lidocaine hydrochloride 20 mg/ml, solution for injection/infusion Ireland - English - HPRA (Health Products Regulatory Authority)

lidocaine hydrochloride 20 mg/ml, solution for injection/infusion

laboratoire aguettant - lidocaine hydrochloride monohydrate - solution for injection/infusion - 20 milligram(s)/millilitre - lidocaine

Lignocaine Hydrochloride New Zealand - English - Medsafe (Medicines Safety Authority)

lignocaine hydrochloride

pharmacia limited company trading as pharmacia - lidocaine hydrochloride monohydrate 1% - solution for injection - 1 % - active: lidocaine hydrochloride monohydrate 1% excipient: sodium chloride water for injection

Lignocaine Hydrochloride New Zealand - English - Medsafe (Medicines Safety Authority)

lignocaine hydrochloride

pharmacia limited company trading as pharmacia - lidocaine hydrochloride monohydrate 2% - solution for injection - 2 % - active: lidocaine hydrochloride monohydrate 2% excipient: sodium chloride water for injection